These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16971387)

  • 1. Dimerization of Laforin is required for its optimal phosphatase activity, regulation of GSK3beta phosphorylation, and Wnt signaling.
    Liu Y; Wang Y; Wu C; Liu Y; Zheng P
    J Biol Chem; 2006 Nov; 281(46):34768-74. PubMed ID: 16971387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation.
    Fernández-Sánchez ME; Criado-García O; Heath KE; García-Fojeda B; Medraño-Fernández I; Gomez-Garre P; Sanz P; Serratosa JM; Rodríguez de Córdoba S
    Hum Mol Genet; 2003 Dec; 12(23):3161-71. PubMed ID: 14532330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation spectrum and predicted function of laforin in Lafora's progressive myoclonus epilepsy.
    Minassian BA; Ianzano L; Meloche M; Andermann E; Rouleau GA; Delgado-Escueta AV; Scherer SW
    Neurology; 2000 Aug; 55(3):341-6. PubMed ID: 10932264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates.
    Worby CA; Gentry MS; Dixon JE
    J Biol Chem; 2006 Oct; 281(41):30412-8. PubMed ID: 16901901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epm2a suppresses tumor growth in an immunocompromised host by inhibiting Wnt signaling.
    Wang Y; Liu Y; Wu C; Zhang H; Zheng X; Zheng Z; Geiger TL; Nuovo GJ; Liu Y; Zheng P
    Cancer Cell; 2006 Sep; 10(3):179-90. PubMed ID: 16959610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laforin negatively regulates cell cycle progression through glycogen synthase kinase 3beta-dependent mechanisms.
    Liu R; Wang L; Chen C; Liu Y; Zhou P; Wang Y; Wang X; Turnbull J; Minassian BA; Liu Y; Zheng P
    Mol Cell Biol; 2008 Dec; 28(23):7236-44. PubMed ID: 18824542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen and related polysaccharides inhibit the laforin dual-specificity protein phosphatase.
    Wang W; Roach PJ
    Biochem Biophys Res Commun; 2004 Dec; 325(3):726-30. PubMed ID: 15541350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies.
    Ganesh S; Tsurutani N; Suzuki T; Hoshii Y; Ishihara T; Delgado-Escueta AV; Yamakawa K
    Biochem Biophys Res Commun; 2004 Jan; 313(4):1101-9. PubMed ID: 14706656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between glycogen accumulation and the laforin dual specificity phosphatase.
    Wang W; Parker GE; Skurat AV; Raben N; DePaoli-Roach AA; Roach PJ
    Biochem Biophys Res Commun; 2006 Nov; 350(3):588-92. PubMed ID: 17022935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype.
    Ganesh S; Delgado-Escueta AV; Suzuki T; Francheschetti S; Riggio C; Avanzini G; Rabinowicz A; Bohlega S; Bailey J; Alonso ME; Rasmussen A; Thomson AE; Ochoa A; Prado AJ; Medina MT; Yamakawa K
    Hum Mol Genet; 2002 May; 11(11):1263-71. PubMed ID: 12019207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative splicing modulates subcellular localization of laforin.
    Ganesh S; Suzuki T; Yamakawa K
    Biochem Biophys Res Commun; 2002 Mar; 291(5):1134-7. PubMed ID: 11883934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique carbohydrate binding domain targets the lafora disease phosphatase to glycogen.
    Wang J; Stuckey JA; Wishart MJ; Dixon JE
    J Biol Chem; 2002 Jan; 277(4):2377-80. PubMed ID: 11739371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Lafora disease gene product laforin interacts with HIRIP5, a phylogenetically conserved protein containing a NifU-like domain.
    Ganesh S; Tsurutani N; Suzuki T; Ueda K; Agarwala KL; Osada H; Delgado-Escueta AV; Yamakawa K
    Hum Mol Genet; 2003 Sep; 12(18):2359-68. PubMed ID: 12915448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimeric quaternary structure of human laforin.
    Sankhala RS; Koksal AC; Ho L; Nitschke F; Minassian BA; Cingolani G
    J Biol Chem; 2015 Feb; 290(8):4552-4559. PubMed ID: 25538239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes.
    Ganesh S; Agarwala KL; Ueda K; Akagi T; Shoda K; Usui T; Hashikawa T; Osada H; Delgado-Escueta AV; Yamakawa K
    Hum Mol Genet; 2000 Sep; 9(15):2251-61. PubMed ID: 11001928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy.
    Lohi H; Ianzano L; Zhao XC; Chan EM; Turnbull J; Scherer SW; Ackerley CA; Minassian BA
    Hum Mol Genet; 2005 Sep; 14(18):2727-36. PubMed ID: 16115820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of laforin, a dual-specificity protein phosphatase implicated in Lafora disease.
    Girard JM; Lê KH; Lederer F
    Biochimie; 2006 Dec; 88(12):1961-71. PubMed ID: 17010495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional and developmental expression of Epm2a gene and its evolutionary conservation.
    Ganesh S; Agarwala KL; Amano K; Suzuki T; Delgado-Escueta AV; Yamakawa K
    Biochem Biophys Res Commun; 2001 May; 283(5):1046-53. PubMed ID: 11355878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phosphatase activity of laforin is dispensable to rescue Epm2a-/- mice from Lafora disease.
    Gayarre J; Duran-Trío L; Criado Garcia O; Aguado C; Juana-López L; Crespo I; Knecht E; Bovolenta P; Rodríguez de Córdoba S
    Brain; 2014 Mar; 137(Pt 3):806-18. PubMed ID: 24430976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimerization of the glucan phosphatase laforin requires the participation of cysteine 329.
    Sánchez-Martín P; Raththagala M; Bridges TM; Husodo S; Gentry MS; Sanz P; Romá-Mateo C
    PLoS One; 2013; 8(7):e69523. PubMed ID: 23922729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.